FundedIQ
Biotechnology

Fluent BioSciences: Funding, Investors & Team (Sep 2026)

Fluent Biosciences is a life science "single cell" technology company that offers molecular analysis of cells without the use of complex microfluidic instrumentation. The company’s proprietary platform, Pre-Templated Instant Partitions (PIPseqTM), provides instantaneous self-assembly of individual cells or molecules into millions of uniform partitions for sensitive, unbiased preparation of proteins and nucleic acids for sequencing applications. Fluent's technology expands accessibility of single cell, molecule, or protein analysis to every laboratory, enabling broader market access across all researchers in biotech, pharma, and academic centers.

www.fluentbio.com LinkedIn Watertown, United States 11-50 employees
Total raised
$1.7M
Rounds
3
Latest
Undisclosed round
Mar 2024

Fluent BioSciences has raised $1.7M across 3 funding rounds on record, the most recent an undisclosed round announced in Mar 2024.

Fluent BioSciences Company Profile and Key Stats

Total funding raised
$1.7M
across 3 rounds on record
Funding rounds on record
3
2 with no disclosed amount
Latest funding round
Undisclosed round
Mar 2024
Employees
11-50
reported band
Headquarters
Watertown, United States

Latest funding round on record: Mar 2024.

Fluent BioSciences Funding Rounds

Date
Round
Amount
Undisclosed round
Undisclosed
Undisclosed round
Undisclosed
Grant
$1.7M

2 of 3 rounds were announced without a disclosed amount and are excluded from the total.

Fluent BioSciences raised $1.7M in a Grant announced in Mar 2022.

1.5 years later, an undisclosed round was announced in Sep 2023 with no disclosed amount.

6 months later, an undisclosed round was announced in Mar 2024 with no disclosed amount.

Fluent BioSciences Founders and Leadership Team

Name
Role
Contact
Sepehr Kiani
CEO
Locked

Contact details for the Fluent BioSciences team: 1 of 1 has an email address on file.

Start 14-day free trial →

Fluent BioSciences Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,179
$8.0M
29,722
$7.5M

Funded Startups Like Fluent BioSciences in Biotechnology and Watertown

Companies Similar to Fluent BioSciences

Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…

Convertible Note $6.8M

XiltriX North America is an information technology company that specializes in monitoring, predictive…

Undisclosed round $3.0M

Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…

Seed $3.1M

Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…

Series D $66.0M

Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…

Series B $92.7M

Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…

Series C $110M

InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…

Series B $77.0M

Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…

Series A $6.3M

Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.

Series C $90.0M

Cataract surgery is the single most common procedure performed in the United States annually. Despite…

Series A $7.0M

InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…

Convertible Note $1.3M

Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…

Series A $10.0M

Fluent BioSciences Funding FAQs

What does Fluent BioSciences do?

Fluent Biosciences is a life science "single cell" technology company that offers molecular analysis of cells without the use of complex microfluidic instrumentation. The company’s proprietary platform, Pre-Templated Instant Partitions (PIPseqTM), provides instantaneous self-assembly of individual cells or molecules into millions of uniform partitions for sensitive, unbiased preparation of proteins and nucleic acids for sequencing applications. Fluent's technology expands accessibility of single cell, molecule, or protein analysis to every laboratory, enabling broader market access across all researchers in biotech, pharma, and academic centers.

How much funding has Fluent BioSciences raised?

Fluent BioSciences has raised $1.7M across 3 rounds on record.

When did Fluent BioSciences last raise funding?

Fluent BioSciences' most recent funding round on record was announced in Mar 2024. The amount was not disclosed.

Who is the CEO of Fluent BioSciences?

Sepehr Kiani is listed as CEO at Fluent BioSciences.

Where is Fluent BioSciences headquartered?

Fluent BioSciences is based in Watertown, Massachusetts, United States.

How many employees does Fluent BioSciences have?

Fluent BioSciences is in the 11-50 employee band.

About FundedIQ's Fluent BioSciences Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Fluent BioSciences is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.